Fibromyalgia / Edition 1

Fibromyalgia / Edition 1

by Daniel Clauw, Daniel Wallace
     
 

Characterized by chronic widespread pain, fibromyalgia presents complex problems in both its diagnosis and treatment. Fibromyalgia is a fairly common condition, affecting 2-4% of the population. The condition's prevalence has increased dramatically since 1990. The condition is not new, but has been known by various names, such as fibrositis and myofascial pain

See more details below

Overview

Characterized by chronic widespread pain, fibromyalgia presents complex problems in both its diagnosis and treatment. Fibromyalgia is a fairly common condition, affecting 2-4% of the population. The condition's prevalence has increased dramatically since 1990. The condition is not new, but has been known by various names, such as fibrositis and myofascial pain syndrome until 1990, when the American College of Rheumatology (ACR) published new classification criteria and first used the name fibromyalgia. The absence of objective diagnostic testing and the overlap with other condition often leads to a significant delay in diagnosis. There is a general misconception that the condition is unresponsive to treatment. However, published research shows that diagnosing and managing fibromyalgia leads to meaningful improvement in the patient's symptons and quality of life. Patients with fibromyalgia often demonstrate symptons additional to pain and are consquently diagnosed with one or more co-occurring syndromes and conditions, complicating diagnosis and treatment. The comorbidities most commonly associated wtih fibromyalgia are sleep disturbance, depression, anxiety, and other psychiatric disorders. Another condition frequently demonstrated by fibromylgia patients is irritable bowel syndrome. Chronic fatigue syndrome also commonly co-occurs, and is often confused wtih fibromyalgia upon initial diagnosis. Numerous pharmacological therapy options exist to treat pain and related symptons of fibromyalgia. Achievement of desired treatment outcomes requires careful patient selection, drug administration and monitoring. Accurate diagnosis of chronic pain syndromes is critical, as some commonly used medications to treat many pain conditions are relatively ineffective wtih fibromyalgia. Despite increasing recognition as a relatively common cause of chronic pain, fibromyalgia continues to generate controversy among clinicians. Given the intricate and

Read More

Product Details

ISBN-13:
9780195384413
Publisher:
Oxford University Press, USA
Publication date:
04/26/2010
Series:
Oxford American Respiratory Library Series
Pages:
112
Product dimensions:
4.90(w) x 7.90(h) x 0.30(d)

Meet the Author

Daniel J. Clauw, MD, is the Assistant Dean for Clinical and Translational Research, Professor of Internal Medicine and Director of the Chronic Pain and Fatigue Center at the University of Michigan Center for the Advancement of Clinical Research.

Daniel Wallace is a clinical professor of Medicine at the David Geffen School of Medicine at UCLA.

Table of Contents

1 History of fibromyalgia 1

2 Definitions and classification 7

3 Epidemiology 13

4 Etiology and pathogenesis 19

5 Clinical findings---symptoms and signs 31

6 Laboratory and imaging correlates 41

7 Clinical associations and subsets 43

8 Differential diagnosis 51

9 Methods of clinical assessment and ascertainment 55

10 General concepts of treatment 57

11 Specific pharmacological and procedural approaches 65

12 Economic impact and disability issues 77

13 Prognosis 81

14 Experimental and innovative therapies 83

Appendix 1 Resource information 85

Appendix 2 Glossary 87

Index 97

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >